Skip to content

KINNEVIK AB (PUBL)

Follow

13F filer, CIK 1766574, STOCKHOLM, Sweden

KINNEVIK AB (PUBL) reported $71,066,765 across 1 holding for the quarter ended 2025-03-31, in a 13F-HR filed 2025-04-28.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-25-040213

Period
2025-03-31
Reported value
$71.1M
Holdings
1
Top 10 weight
100%
New
0
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
RXRXadded+1,528,503$8.09M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

None.

Holdings, Q1 2025

Share positions as resolved from 13F-HR 0001104659-25-040213, largest first. % of portfolio is the value over $71,066,765, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RXRXRECURSION PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 10,405,668 shares; 2024Q1: 10,405,668 shares; 2024Q2: 11,905,668 shares; 2024Q3: 11,905,668 shares; 2024Q4: 11,905,668 shares; 2025Q1: 13,434,171 shares 13,434,171$71.1M100%+1,528,503Timeline

How Q1 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-25-040213 base2025-04-28acceptance time not in the bulk data set